302 related articles for article (PubMed ID: 26748827)
1. MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53.
Wienken M; Dickmanns A; Nemajerova A; Kramer D; Najafova Z; Weiss M; Karpiuk O; Kassem M; Zhang Y; Lozano G; Johnsen SA; Moll UM; Zhang X; Dobbelstein M
Mol Cell; 2016 Jan; 61(1):68-83. PubMed ID: 26748827
[TBL] [Abstract][Full Text] [Related]
2. Mdm2 as a chromatin modifier.
Wienken M; Moll UM; Dobbelstein M
J Mol Cell Biol; 2017 Feb; 9(1):74-80. PubMed ID: 27927750
[TBL] [Abstract][Full Text] [Related]
3. Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication.
Klusmann I; Wohlberedt K; Magerhans A; Teloni F; Korbel JO; Altmeyer M; Dobbelstein M
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11311-E11320. PubMed ID: 30413623
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stability.
Wen W; Peng C; Kim MO; Ho Jeong C; Zhu F; Yao K; Zykova T; Ma W; Carper A; Langfald A; Bode AM; Dong Z
Oncogene; 2014 Jan; 33(4):421-8. PubMed ID: 23318437
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.
Xu C; Fan CD; Wang X
Oncogene; 2015 Jan; 34(3):281-9. PubMed ID: 24413081
[TBL] [Abstract][Full Text] [Related]
6. HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis.
Chen Y; Pan K; Wang P; Cao Z; Wang W; Wang S; Hu N; Xue J; Li H; Jiang W; Li G; Zhang X
J Biol Chem; 2016 Jun; 291(24):12688-12705. PubMed ID: 27129219
[TBL] [Abstract][Full Text] [Related]
7. RNF2/Ring1b negatively regulates p53 expression in selective cancer cell types to promote tumor development.
Su WJ; Fang JS; Cheng F; Liu C; Zhou F; Zhang J
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1720-5. PubMed ID: 23319651
[TBL] [Abstract][Full Text] [Related]
8. Histone H2AK119 Mono-Ubiquitination Is Essential for Polycomb-Mediated Transcriptional Repression.
Tamburri S; Lavarone E; Fernández-Pérez D; Conway E; Zanotti M; Manganaro D; Pasini D
Mol Cell; 2020 Feb; 77(4):840-856.e5. PubMed ID: 31883952
[TBL] [Abstract][Full Text] [Related]
9. FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53.
Ochocka AM; Kampanis P; Nicol S; Allende-Vega N; Cox M; Marcar L; Milne D; Fuller-Pace F; Meek D
FEBS Lett; 2009 Feb; 583(4):621-6. PubMed ID: 19166840
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.
Zhao K; Yang Y; Zhang G; Wang C; Wang D; Wu M; Mei Y
EMBO Rep; 2018 Feb; 19(2):305-319. PubMed ID: 29295817
[TBL] [Abstract][Full Text] [Related]
11. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
[TBL] [Abstract][Full Text] [Related]
12. Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53.
Riscal R; Schrepfer E; Arena G; Cissé MY; Bellvert F; Heuillet M; Rambow F; Bonneil E; Sabourdy F; Vincent C; Ait-Arsa I; Levade T; Thibaut P; Marine JC; Portais JC; Sarry JE; Le Cam L; Linares LK
Mol Cell; 2016 Jun; 62(6):890-902. PubMed ID: 27264869
[TBL] [Abstract][Full Text] [Related]
13. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation.
Calao M; Sekyere EO; Cui HJ; Cheung BB; Thomas WD; Keating J; Chen JB; Raif A; Jankowski K; Davies NP; Bekkum MV; Chen B; Tan O; Ellis T; Norris MD; Haber M; Kim ES; Shohet JM; Trahair TN; Liu T; Wainwright BJ; Ding HF; Marshall GM
Oncogene; 2013 Aug; 32(31):3616-26. PubMed ID: 22907436
[TBL] [Abstract][Full Text] [Related]
14. RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage.
Fu X; Yucer N; Liu S; Li M; Yi P; Mu JJ; Yang T; Chu J; Jung SY; O'Malley BW; Gu W; Qin J; Wang Y
Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4579-84. PubMed ID: 20173098
[TBL] [Abstract][Full Text] [Related]
15. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
[TBL] [Abstract][Full Text] [Related]
16. USP49-Mediated Histone H2B Deubiquitination Regulates HCT116 Cell Proliferation through MDM2-p53 Axis.
Shi L; Shen X; Shen Y
Mol Cell Biol; 2022 Mar; 42(3):e0043421. PubMed ID: 35072515
[TBL] [Abstract][Full Text] [Related]
17. Ring1B compacts chromatin structure and represses gene expression independent of histone ubiquitination.
Eskeland R; Leeb M; Grimes GR; Kress C; Boyle S; Sproul D; Gilbert N; Fan Y; Skoultchi AI; Wutz A; Bickmore WA
Mol Cell; 2010 May; 38(3):452-64. PubMed ID: 20471950
[TBL] [Abstract][Full Text] [Related]
18. PRC1 catalytic unit RING1B regulates early neural differentiation of human pluripotent stem cells.
Desai D; Khanna A; Pethe P
Exp Cell Res; 2020 Nov; 396(1):112294. PubMed ID: 32971117
[TBL] [Abstract][Full Text] [Related]
19. The E3 ubiquitin ligase activity of RING1B is not essential for early mouse development.
Illingworth RS; Moffat M; Mann AR; Read D; Hunter CJ; Pradeepa MM; Adams IR; Bickmore WA
Genes Dev; 2015 Sep; 29(18):1897-902. PubMed ID: 26385961
[TBL] [Abstract][Full Text] [Related]
20. p53 ubiquitination: Mdm2 and beyond.
Brooks CL; Gu W
Mol Cell; 2006 Feb; 21(3):307-15. PubMed ID: 16455486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
